Breaking News

Over a month ago
Show Full Stories

X

To view all stories in expanded form, please subscribe.
Send Info
Initiation
HealthEquity initiated with a Sell at Goldman Sachs » 04:56
07/12/22
07/12
04:56
07/12/22
04:56
HQY

HealthEquity

$61.88 /

-3.63 (-5.54%)

Goldman Sachs analyst…

Goldman Sachs analyst Cindy Motz initiated coverage of HealthEquity with a Sell rating and $59 price target. Investors have viewed the stock as a play on higher interest rates which has benefited the company in prior rising interest rate cycles, but HealthEquity has commented that it does not expect to see a huge lift from rising interest rates any time soon, Motz tells investors in a research note. The analyst is not convinced the company's organic health savings account growth will be enough to support current valuations.

ShowHide Related Items >><<
HQY HealthEquity
$61.88 /

-3.63 (-5.54%)

06/08/22 Deutsche Bank
HealthEquity price target raised to $67 from $66 at Deutsche Bank
06/07/22 Barrington
HealthEquity price target raised to $75 from $70 at Barrington
04/11/22 Wells Fargo
HealthEquity initiated with an Overweight at Wells Fargo
04/07/22 Guggenheim
Guggenheim starts HealthEquity at Buy with $89 price target
HQY HealthEquity
$61.88 /

-3.63 (-5.54%)

  • 17
    Aug
HQY HealthEquity
$61.88 /

-3.63 (-5.54%)

Recommendations
HealthEquity price target raised to $67 from $66 at Deutsche Bank » 07:30
06/08/22
06/08
07:30
06/08/22
07:30
HQY

HealthEquity

$65.36 /

+3.065 (+4.92%)

Deutsche Bank analyst…

Deutsche Bank analyst George Hill raised the firm's price target on HealthEquity to $67 from $66 and keeps a Buy rating on the shares following the "solid" fiscal Q1 report. The company reported a modest earnings beat and updated guidance, which is effectively unchanged for the balance of the year, Hill tells investors in a research note. The analyst says the results were generally well received by investors.

ShowHide Related Items >><<
HQY HealthEquity
$65.36 /

+3.065 (+4.92%)

HQY HealthEquity
$65.36 /

+3.065 (+4.92%)

06/07/22 Barrington
HealthEquity price target raised to $75 from $70 at Barrington
04/11/22 Wells Fargo
HealthEquity initiated with an Overweight at Wells Fargo
04/07/22 Guggenheim
Guggenheim starts HealthEquity at Buy with $89 price target
04/06/22 Guggenheim
HealthEquity initiated with a Buy at Guggenheim
HQY HealthEquity
$65.36 /

+3.065 (+4.92%)

  • 17
    Aug
HQY HealthEquity
$65.36 /

+3.065 (+4.92%)

Recommendations
HealthEquity price target raised to $75 from $70 at Barrington » 10:14
06/07/22
06/07
10:14
06/07/22
10:14
HQY

HealthEquity

$64.96 /

+2.67 (+4.29%)

Barrington analyst…

Barrington analyst Alexander Paris raised the firm's price target on HealthEquity to $75 from $70 and reiterates an Outperform rating on the shares post the Q1 beat. With a strong core health savings account business, HealthEquity's operating and financial performance should improve on a consolidated basis as the economy continues to reopen and current industry headwinds abate, Paris tells investors in a research note. He sees 20% upside from current share levels.

ShowHide Related Items >><<
HQY HealthEquity
$64.96 /

+2.67 (+4.29%)

HQY HealthEquity
$64.96 /

+2.67 (+4.29%)

04/11/22 Wells Fargo
HealthEquity initiated with an Overweight at Wells Fargo
04/07/22 Guggenheim
Guggenheim starts HealthEquity at Buy with $89 price target
04/06/22 Guggenheim
HealthEquity initiated with a Buy at Guggenheim
03/30/22 BTIG
HealthEquity upgraded to Buy at BTIG on higher utilization of healthcare service
HQY HealthEquity
$64.96 /

+2.67 (+4.29%)

  • 17
    Aug
HQY HealthEquity
$64.96 /

+2.67 (+4.29%)

On The Fly
Fly Intel: Pre-market Movers » 08:49
06/07/22
06/07
08:49
06/07/22
08:49
TGT

Target

$159.82 /

-1.24 (-0.77%)

, WMT

Walmart

$124.88 /

-0.45 (-0.36%)

, KSS

Kohl's

$41.64 /

+0.635 (+1.55%)

, FRG

Franchise Group

$36.98 /

+0.28 (+0.76%)

, GTLB

GitLab

$39.84 /

-1.14 (-2.78%)

, HQY

HealthEquity

$62.29 /

-1.93 (-3.01%)

, GIII

G-III Apparel

$27.36 /

+0.55 (+2.05%)

, SJM

J.M. Smucker

$123.16 /

+0.41 (+0.33%)

, VERU

Veru

$13.57 /

-0.89 (-6.15%)

, PLAY

Dave & Buster's

$37.22 /

+1.665 (+4.68%)

, UNP

Union Pacific

$225.06 /

+1.1 (+0.49%)

, CHS

Chico's

$4.85 /

+0.02 (+0.41%)

Check out this morning's…

ShowHide Related Items >><<
WMT Walmart
$124.88 /

-0.45 (-0.36%)

VERU Veru
$13.57 /

-0.89 (-6.15%)

UNP Union Pacific
$225.06 /

+1.1 (+0.49%)

TGT Target
$159.82 /

-1.24 (-0.77%)

SJM J.M. Smucker
$123.16 /

+0.41 (+0.33%)

PLAY Dave & Buster's
$37.22 /

+1.665 (+4.68%)

KSS Kohl's
$41.64 /

+0.635 (+1.55%)

HQY HealthEquity
$62.29 /

-1.93 (-3.01%)

GTLB GitLab
$39.84 /

-1.14 (-2.78%)

GIII G-III Apparel
$27.36 /

+0.55 (+2.05%)

FRG Franchise Group
$36.98 /

+0.28 (+0.76%)

CHS Chico's
$4.85 /

+0.02 (+0.41%)

TGT Target
$159.82 /

-1.24 (-0.77%)

05/27/22 DA Davidson
Ulta Beauty price target raised to $465 from $450 at DA Davidson
05/26/22 UBS
UBS cuts Kraft Heinz to Sell, sees private label trade-down risk not priced in
05/23/22 Credit Suisse
Target price target lowered to $180 from $286 at Credit Suisse
05/19/22 Jefferies
Target price target lowered to $168 from $252 at Jefferies
WMT Walmart
$124.88 /

-0.45 (-0.36%)

06/06/22 Morgan Stanley
Walmart's 'no new bad news' meeting should be a positive, says Morgan Stanley
06/05/22 Baird
Baird remains bullish on Walmart following shareholders meeting
05/26/22 Oppenheimer
Oppenheimer continues to favor Teladoc, new policies positive for telehealth
KSS Kohl's
$41.64 /

+0.635 (+1.55%)

05/23/22 Citi
Kohl's downgraded to Neutral from Buy at Citi
05/20/22 Morgan Stanley
Kohl's price target lowered to $38 from $42 at Morgan Stanley
05/20/22 Cowen
Kohl's price target lowered to $60 from $75 at Cowen
05/20/22 Deutsche Bank
Kohl's price target lowered to $68 from $85 at Deutsche Bank
FRG Franchise Group
$36.98 /

+0.28 (+0.76%)

05/06/22 B. Riley
Franchise Group price target lowered to $63 from $65 at B. Riley
01/03/22 B. Riley
iStar, Aspen Aerogels among B. Riley's top 25 stock picks for 2022
12/08/21 Barrington
Franchise Group price target raised to $65 from $58 at Barrington
12/08/21 B. Riley
B. Riley remains buyer of Franchise Group after outlook tops estimates
GTLB GitLab
$39.84 /

-1.14 (-2.78%)

06/07/22 UBS
GitLab price target raised to $59 from $54 at UBS
06/07/22 Truist
GitLab demonstrating 'outstanding growth', says Truist
06/07/22 RBC Capital
GitLab price target raised to $66 from $64 at RBC Capital
06/07/22 Piper Sandler
GitLab price target lowered to $60 from $75 at Piper Sandler
HQY HealthEquity
$62.29 /

-1.93 (-3.01%)

04/11/22 Wells Fargo
HealthEquity initiated with an Overweight at Wells Fargo
04/07/22 Guggenheim
Guggenheim starts HealthEquity at Buy with $89 price target
04/06/22 Guggenheim
HealthEquity initiated with a Buy at Guggenheim
03/30/22 BTIG
HealthEquity upgraded to Buy at BTIG on higher utilization of healthcare service
GIII G-III Apparel
$27.36 /

+0.55 (+2.05%)

06/07/22 CL King
G-III Apparel's Q1 results viewed 'positively,' says CL King
06/08/21 B. Riley
G-III Apparel price target raised to $41 from $39 at B. Riley
06/08/21 Barclays
G-III Apparel price target raised to $30 from $27 at Barclays
SJM J.M. Smucker
$123.16 /

+0.41 (+0.33%)

06/01/22 Deutsche Bank
J.M. Smucker price target lowered to $133 from $134 at Deutsche Bank
03/30/22 UBS
J.M. Smucker initiated with a Sell at UBS
03/02/22 Credit Suisse
J.M. Smucker price target lowered to $130 from $140 at Credit Suisse
03/02/22 Citi
J.M. Smucker price target lowered to $131 from $138 at Citi
VERU Veru
$13.57 /

-0.89 (-6.15%)

05/18/22 Brookline
Veru price target raised to $31 from $29 at Brookline
05/13/22 Jefferies
Veru price target raised to $55 from $33 at Jefferies
04/12/22 Oppenheimer
Veru price target raised to $36 from $25 at Oppenheimer
04/11/22 Cantor Fitzgerald
Veru's Covid data highlights multiple shots on goal, says Cantor Fitzgerald
PLAY Dave & Buster's
$37.22 /

+1.665 (+4.68%)

06/03/22 Truist
Dave & Buster's price target lowered to $63 from $68 at Truist
04/13/22 Jefferies
Dave & Buster's deal for Main Event 'very positive' for growth, says Jefferies
04/06/22 Stifel
Acquisition of Main Event 'a bold move' for Dave & Buster's, says Stifel
03/30/22 BMO Capital
Dave & Buster's price target raised to $62 from $58 at BMO Capital
UNP Union Pacific
$225.06 /

+1.1 (+0.49%)

05/26/22 Evercore ISI
Union Pacific downgraded to In Line from Outperform at Evercore ISI
05/19/22 Citi
Union Pacific downgraded to Neutral from Buy at Citi
04/22/22 Raymond James
Union Pacific price target raised to $285 from $280 at Raymond James
04/22/22 UBS
UBS cuts Union Pacific to Neutral on capacity constraints and service issues
CHS Chico's
$4.85 /

+0.02 (+0.41%)

03/02/22 B. Riley
Chico's price target lowered to $5 from $6 at B. Riley
12/01/21 B. Riley
Chico's price target raised to $6 from $5.25 at B. Riley
06/09/21 B. Riley
Chico's price target raised to $5.25 from $2.50 at B. Riley
WMT Walmart
$124.88 /

-0.45 (-0.36%)

VERU Veru
$13.57 /

-0.89 (-6.15%)

UNP Union Pacific
$225.06 /

+1.1 (+0.49%)

TGT Target
$159.82 /

-1.24 (-0.77%)

SJM J.M. Smucker
$123.16 /

+0.41 (+0.33%)

PLAY Dave & Buster's
$37.22 /

+1.665 (+4.68%)

KSS Kohl's
$41.64 /

+0.635 (+1.55%)

HQY HealthEquity
$62.29 /

-1.93 (-3.01%)

GTLB GitLab
$39.84 /

-1.14 (-2.78%)

GIII G-III Apparel
$27.36 /

+0.55 (+2.05%)

FRG Franchise Group
$36.98 /

+0.28 (+0.76%)

CHS Chico's
$4.85 /

+0.02 (+0.41%)

  • 14
    Oct
  • 17
    Aug
WMT Walmart
$124.88 /

-0.45 (-0.36%)

VERU Veru
$13.57 /

-0.89 (-6.15%)

UNP Union Pacific
$225.06 /

+1.1 (+0.49%)

TGT Target
$159.82 /

-1.24 (-0.77%)

KSS Kohl's
$41.64 /

+0.635 (+1.55%)

FRG Franchise Group
$36.98 /

+0.28 (+0.76%)

WMT Walmart
$124.88 /

-0.45 (-0.36%)

VERU Veru
$13.57 /

-0.89 (-6.15%)

UNP Union Pacific
$225.06 /

+1.1 (+0.49%)

TGT Target
$159.82 /

-1.24 (-0.77%)

SJM J.M. Smucker
$123.16 /

+0.41 (+0.33%)

PLAY Dave & Buster's
$37.22 /

+1.665 (+4.68%)

KSS Kohl's
$41.64 /

+0.635 (+1.55%)

HQY HealthEquity
$62.29 /

-1.93 (-3.01%)

GTLB GitLab
$39.84 /

-1.14 (-2.78%)

GIII G-III Apparel
$27.36 /

+0.55 (+2.05%)

FRG Franchise Group
$36.98 /

+0.28 (+0.76%)

CHS Chico's
$4.85 /

+0.02 (+0.41%)

WMT Walmart
$124.88 /

-0.45 (-0.36%)

VERU Veru
$13.57 /

-0.89 (-6.15%)

UNP Union Pacific
$225.06 /

+1.1 (+0.49%)

TGT Target
$159.82 /

-1.24 (-0.77%)

PLAY Dave & Buster's
$37.22 /

+1.665 (+4.68%)

KSS Kohl's
$41.64 /

+0.635 (+1.55%)

GTLB GitLab
$39.84 /

-1.14 (-2.78%)

On The Fly
Fly Intel: After-Hours Movers » 18:22
06/06/22
06/06
18:22
06/06/22
18:22
GTLB

GitLab

$39.84 /

-1.14 (-2.78%)

, HQY

HealthEquity

$62.29 /

-1.93 (-3.01%)

, ACET

Adicet Bio

$12.24 /

+0.74 (+6.43%)

, IDN

Intellicheck

$1.75 /

+0.02 (+1.16%)

, COUP

Coupa Software

$72.17 /

+1.41 (+1.99%)

, HLBZ

Helbiz

/

+

, AERC

AeroClean

$4.70 /

+2.35 (+100.00%)

, VERU

Veru

$13.57 /

-0.89 (-6.15%)

, NEWR

New Relic

$47.67 /

-0.6 (-1.24%)

, NGL

NGL Energy Partners

$2.12 /

+0.06 (+2.91%)

Check out this evening's…

ShowHide Related Items >><<
VERU Veru
$13.57 /

-0.89 (-6.15%)

NGL NGL Energy Partners
$2.12 /

+0.06 (+2.91%)

NEWR New Relic
$47.67 /

-0.6 (-1.24%)

IDN Intellicheck
$1.75 /

+0.02 (+1.16%)

HQY HealthEquity
$62.29 /

-1.93 (-3.01%)

HLBZ Helbiz
/

+

GTLB GitLab
$39.84 /

-1.14 (-2.78%)

COUP Coupa Software
$72.17 /

+1.41 (+1.99%)

AERC AeroClean
$4.70 /

+2.35 (+100.00%)

ACET Adicet Bio
$12.24 /

+0.74 (+6.43%)

GTLB GitLab
$39.84 /

-1.14 (-2.78%)

05/10/22 Truist
GitLab price target lowered to $95 from $105 at Truist
04/25/22 KeyBanc
GitLab price target raised to $63 from $50 at KeyBanc
04/18/22 RBC Capital
GitLab price target raised to $64 from $60 at RBC Capital
04/14/22 Goldman Sachs
Goldman Sachs encouraged by GitLab trends but sees competitive environment
HQY HealthEquity
$62.29 /

-1.93 (-3.01%)

04/11/22 Wells Fargo
HealthEquity initiated with an Overweight at Wells Fargo
04/07/22 Guggenheim
Guggenheim starts HealthEquity at Buy with $89 price target
04/06/22 Guggenheim
HealthEquity initiated with a Buy at Guggenheim
03/30/22 BTIG
HealthEquity upgraded to Buy at BTIG on higher utilization of healthcare service
ACET Adicet Bio
$12.24 /

+0.74 (+6.43%)

03/30/22 SMBC Nikko
Adicet Bio initiated with an Outperform at SMBC Nikko
03/17/22 JMP Securities
Adicet Bio price target lowered to $21 from $30 at JMP Securities
03/08/22 Truist
Adicet Bio initiated with a Buy at Truist
03/04/22 Jefferies
Adicet Bio initiated with a Buy at Jefferies
IDN Intellicheck
$1.75 /

+0.02 (+1.16%)

03/10/22 DA Davidson
Intellicheck price target lowered to $8.50 from $14 at DA Davidson
03/10/22 Northland
Intellicheck price target lowered to $6 from $11.50 at Northland
03/10/22 H.C. Wainwright
Intellicheck price target lowered to $7 from $15 at H.C. Wainwright
11/11/21 Craig-Hallum
Intellicheck downgraded to Hold from Buy at Craig-Hallum
COUP Coupa Software
$72.17 /

+1.41 (+1.99%)

05/31/22 BofA
Coupa Software price target lowered to $96 from $120 at BofA
05/19/22 DA Davidson
Coupa Software initiated with a Neutral at DA Davidson
05/12/22 Goldman Sachs
Coupa Software downgraded to Sell from Buy at Goldman Sachs
04/08/22 BMO Capital
Coupa Software price target raised to $110 from $82 at BMO Capital
HLBZ Helbiz
/

+

AERC AeroClean
$4.70 /

+2.35 (+100.00%)

06/06/22 Benchmark
AeroClean's Purgo FDA clearance expected to provide advantage, says Benchmark
03/31/22 Benchmark
AeroClean price target lowered to $7 from $10 at Benchmark
02/16/22 Benchmark
AeroClean lands 'prestigious' customer in HSS, says Benchmark
02/01/22 Benchmark
AeroClean initiated with a Speculative Buy at Benchmark
VERU Veru
$13.57 /

-0.89 (-6.15%)

05/18/22 Brookline
Veru price target raised to $31 from $29 at Brookline
05/13/22 Jefferies
Veru price target raised to $55 from $33 at Jefferies
04/12/22 Oppenheimer
Veru price target raised to $36 from $25 at Oppenheimer
04/11/22 Cantor Fitzgerald
Veru's Covid data highlights multiple shots on goal, says Cantor Fitzgerald
NEWR New Relic
$47.67 /

-0.6 (-1.24%)

05/13/22 RBC Capital
New Relic price target lowered to $45 from $90 at RBC Capital
05/13/22 Truist
New Relic price target lowered to $85 from $95 at Truist
05/13/22 BMO Capital
New Relic price target lowered to $50 from $96 at BMO Capital
05/13/22 Cowen
New Relic price target lowered to $65 from $80 at Cowen
NGL NGL Energy Partners
$2.12 /

+0.06 (+2.91%)

VERU Veru
$13.57 /

-0.89 (-6.15%)

NGL NGL Energy Partners
$2.12 /

+0.06 (+2.91%)

NEWR New Relic
$47.67 /

-0.6 (-1.24%)

IDN Intellicheck
$1.75 /

+0.02 (+1.16%)

HQY HealthEquity
$62.29 /

-1.93 (-3.01%)

GTLB GitLab
$39.84 /

-1.14 (-2.78%)

COUP Coupa Software
$72.17 /

+1.41 (+1.99%)

AERC AeroClean
$4.70 /

+2.35 (+100.00%)

ACET Adicet Bio
$12.24 /

+0.74 (+6.43%)

  • 08
    Dec
  • 24
    Nov
  • 14
    Oct
  • 17
    Aug
VERU Veru
$13.57 /

-0.89 (-6.15%)

VERU Veru
$13.57 /

-0.89 (-6.15%)

NGL NGL Energy Partners
$2.12 /

+0.06 (+2.91%)

NEWR New Relic
$47.67 /

-0.6 (-1.24%)

IDN Intellicheck
$1.75 /

+0.02 (+1.16%)

HQY HealthEquity
$62.29 /

-1.93 (-3.01%)

GTLB GitLab
$39.84 /

-1.14 (-2.78%)

COUP Coupa Software
$72.17 /

+1.41 (+1.99%)

AERC AeroClean
$4.70 /

+2.35 (+100.00%)

ACET Adicet Bio
$12.24 /

+0.74 (+6.43%)

VERU Veru
$13.57 /

-0.89 (-6.15%)

NGL NGL Energy Partners
$2.12 /

+0.06 (+2.91%)

NEWR New Relic
$47.67 /

-0.6 (-1.24%)

GTLB GitLab
$39.84 /

-1.14 (-2.78%)

COUP Coupa Software
$72.17 /

+1.41 (+1.99%)

Earnings
HealthEquity ups FY23 EPS view to $1.23-$1.32 from $1.21-$1.30, consensus $1.27 » 16:08
06/06/22
06/06
16:08
06/06/22
16:08
HQY

HealthEquity

$62.47 /

-1.75 (-2.73%)

Raises FY23 revenue view…

Raises FY23 revenue view to $827M-$837M from $820M-$830M, consensus $827.36M. The company said, "For the fiscal year ending January 31, 2023, management expects revenues of $827 million to $837 million. Its outlook for net loss is between $51 million and $43 million, resulting in net loss of $0.61 to $0.51 per diluted share. Its outlook for non-GAAP net income, calculated using the method described below, is between $103 million and $111 million, resulting in non-GAAP net income per diluted share of $1.23 to $1.32 (based on an estimated 84 million diluted weighted-average shares outstanding). Management expects Adjusted EBITDA of $249 million to $259 million."

ShowHide Related Items >><<
HQY HealthEquity
$62.47 /

-1.75 (-2.73%)

HQY HealthEquity
$62.47 /

-1.75 (-2.73%)

04/11/22 Wells Fargo
HealthEquity initiated with an Overweight at Wells Fargo
04/07/22 Guggenheim
Guggenheim starts HealthEquity at Buy with $89 price target
04/06/22 Guggenheim
HealthEquity initiated with a Buy at Guggenheim
03/30/22 BTIG
HealthEquity upgraded to Buy at BTIG on higher utilization of healthcare service
HQY HealthEquity
$62.47 /

-1.75 (-2.73%)

  • 17
    Aug
HQY HealthEquity
$62.47 /

-1.75 (-2.73%)

Earnings
HealthEquity reports Q1 EPS 27c, consensus 26c » 16:04
06/06/22
06/06
16:04
06/06/22
16:04
HQY

HealthEquity

$62.65 /

-1.57 (-2.44%)

Reports Q1 revenue…

Reports Q1 revenue $205.68M, consensus $203.98M. Reports 7.4M HSAs, an increase of 26% compared to Q1 FY22. "We started fiscal year 2023 with record new HSA sales for a first quarter and overall highs for Total HSA Assets, HSAs, Total Accounts, and quarterly revenue," said Jon Kessler, president and CEO of HealthEquity. "With the benefit of an improved economy and higher interest rates, we are off to a fast start for the fiscal year and are well-positioned to outpace the market and deliver strong revenue and adjusted EBITDA in fiscal 2023."

ShowHide Related Items >><<
HQY HealthEquity
$62.65 /

-1.57 (-2.44%)

HQY HealthEquity
$62.65 /

-1.57 (-2.44%)

04/11/22 Wells Fargo
HealthEquity initiated with an Overweight at Wells Fargo
04/07/22 Guggenheim
Guggenheim starts HealthEquity at Buy with $89 price target
04/06/22 Guggenheim
HealthEquity initiated with a Buy at Guggenheim
03/30/22 BTIG
HealthEquity upgraded to Buy at BTIG on higher utilization of healthcare service
HQY HealthEquity
$62.65 /

-1.57 (-2.44%)

  • 17
    Aug
HQY HealthEquity
$62.65 /

-1.57 (-2.44%)

Over a quarter ago
Conference/Events
HealthEquity management to meet virtually with Stephens » 04:55
04/12/22
04/12
04:55
04/12/22
04:55
HQY

HealthEquity

$67.98 /

+0.8 (+1.19%)

Virtual Meeting to be…

Virtual Meeting to be held on April 12 hosted by Stephens.

ShowHide Related Items >><<
HQY HealthEquity
$67.98 /

+0.8 (+1.19%)

HQY HealthEquity
$67.98 /

+0.8 (+1.19%)

04/11/22 Wells Fargo
HealthEquity initiated with an Overweight at Wells Fargo
04/07/22 Guggenheim
Guggenheim starts HealthEquity at Buy with $89 price target
04/06/22 Guggenheim
HealthEquity initiated with a Buy at Guggenheim
03/30/22 BTIG
HealthEquity upgraded to Buy at BTIG on higher utilization of healthcare service
HQY HealthEquity
$67.98 /

+0.8 (+1.19%)

  • 17
    Aug
HQY HealthEquity
$67.98 /

+0.8 (+1.19%)

HQY HealthEquity
$67.98 /

+0.8 (+1.19%)

Initiation
HealthEquity initiated with an Overweight at Wells Fargo » 06:37
04/11/22
04/11
06:37
04/11/22
06:37
HQY

HealthEquity

$67.30 /

+0.125 (+0.19%)

Wells Fargo analyst Stan…

Wells Fargo analyst Stan Berenshteyn initiated coverage of HealthEquity with an Overweight rating and $95 price target. The analyst expects the broader HSA market to remain a tailwind, as he anticipates HSA members/assets expanding from 30M/$100B today toward 60M/$300B over the next decade. Berenshteyn is attracted to HealthEquity's high incremental margins that are complimented by its capital-light operating model, and thinsk the business can approach 30% free cash flow margin by fiscal 2030. Although shares have begun to rebound with short-term treasury rates moving up, the analyst doesn't think the magnitude of the current rate environment is fully baked into expectations. In his view, fiscal 2025 will see revenue growth accelerate to about 21%, as drag from custodial rates should flip to a tailwind; a dynamic he thinks is not fully captured by consensus estimates.

ShowHide Related Items >><<
HQY HealthEquity
$67.30 /

+0.125 (+0.19%)

HQY HealthEquity
$67.30 /

+0.125 (+0.19%)

04/07/22 Guggenheim
Guggenheim starts HealthEquity at Buy with $89 price target
04/06/22 Guggenheim
HealthEquity initiated with a Buy at Guggenheim
03/30/22 BTIG
HealthEquity upgraded to Buy at BTIG on higher utilization of healthcare service
03/30/22 BTIG
HealthEquity upgraded to Buy from Neutral at BTIG
HQY HealthEquity
$67.30 /

+0.125 (+0.19%)

  • 17
    Aug
HQY HealthEquity
$67.30 /

+0.125 (+0.19%)

HQY HealthEquity
$67.30 /

+0.125 (+0.19%)

On The Fly
Street Wrap: Today's Top 15 Upgrades, Downgrades, Initiations » 10:05
04/07/22
04/07
10:05
04/07/22
10:05
AN

AutoNation

$98.53 /

+0.74 (+0.76%)

, YETI

Yeti

$56.09 /

+1.14 (+2.07%)

, ARRY

Array Technologies

$10.42 /

-0.585 (-5.32%)

, ZETA

Zeta Global

$12.50 /

+0.395 (+3.26%)

, AJRD

Aerojet Rocketdyne

$41.75 /

+1.61 (+4.01%)

, W

Wayfair

$106.96 /

+0.02 (+0.02%)

, F

Ford

$15.00 /

-0.395 (-2.57%)

, RAD

Rite Aid

$6.69 /

-1.755 (-20.79%)

, HLI

Houlihan Lokey

$82.41 /

-1.82 (-2.16%)

, HIMX

Himax

$9.71 /

-0.705 (-6.77%)

, RBLX

Roblox

$45.44 /

-0.41 (-0.89%)

, U

Unity

$93.82 /

+ (+0.00%)

, TDOC

Teladoc

$67.96 /

+0.185 (+0.27%)

, SYNA

Synaptics

$168.70 /

-1.35 (-0.79%)

, DOCS

Doximity

$50.85 /

-0.64 (-1.24%)

, GDRX

GoodRx

$18.90 /

+0.18 (+0.96%)

, CNVY

Convey Health

$6.61 /

+0.12 (+1.85%)

, HQY

HealthEquity

$67.50 /

+ (+0.00%)

, ACCD

Accolade

$15.97 /

-0.7 (-4.20%)

Institutional investors…

ShowHide Related Items >><<
ZETA Zeta Global
$12.50 /

+0.395 (+3.26%)

YETI Yeti
$56.09 /

+1.14 (+2.07%)

W Wayfair
$106.96 /

+0.02 (+0.02%)

U Unity
$93.82 /

+ (+0.00%)

TDOC Teladoc
$67.96 /

+0.185 (+0.27%)

SYNA Synaptics
$168.70 /

-1.35 (-0.79%)

RBLX Roblox
$45.44 /

-0.41 (-0.89%)

RAD Rite Aid
$6.69 /

-1.755 (-20.79%)

HQY HealthEquity
$67.50 /

+ (+0.00%)

HIMX Himax
$9.71 /

-0.705 (-6.77%)

GDRX GoodRx
$18.90 /

+0.18 (+0.96%)

F Ford
$15.00 /

-0.395 (-2.57%)

DOCS Doximity
$50.85 /

-0.64 (-1.24%)

CNVY Convey Health
$6.61 /

+0.12 (+1.85%)

ARRY Array Technologies
$10.42 /

-0.585 (-5.32%)

AN AutoNation
$98.53 /

+0.74 (+0.76%)

AJRD Aerojet Rocketdyne
$41.75 /

+1.61 (+4.01%)

ACCD Accolade
$15.97 /

-0.7 (-4.20%)

AN AutoNation
$98.53 /

+0.74 (+0.76%)

04/07/22 JPMorgan
AutoNation upgraded to Overweight from Neutral at JPMorgan
01/18/22 Wells Fargo
AutoNation initiated with an Overweight at Wells Fargo
11/17/21 Morgan Stanley
AutoNation price target lowered to $103 from $116 at Morgan Stanley
10/22/21 Truist
AutoNation price target raised to $130 from $110 at Truist
YETI Yeti
$56.09 /

+1.14 (+2.07%)

04/07/22 Berenberg
Yeti upgraded to Buy from Hold at Berenberg
03/03/22 Jefferies
Jefferies sees Yeti trading at 'extremely attractive entry point'
02/18/22 Citi
Yeti price target lowered to $83 from $95 at Citi
02/18/22 Raymond James
Yeti price target lowered to $86 from $111 at Raymond James
ARRY Array Technologies
$10.42 /

-0.585 (-5.32%)

04/07/22 Guggenheim
Array Technologies upgraded to Buy yesterday at Guggenheim
04/06/22 Guggenheim
Array Technologies upgraded to Buy from Neutral at Guggenheim
01/31/22 Goldman Sachs
Array Technologies price target lowered to $20 from $24 at Goldman Sachs
01/24/22 Truist
Array Technologies price target lowered to $14 from $27 at Truist
ZETA Zeta Global
$12.50 /

+0.395 (+3.26%)

04/07/22 Oppenheimer
Zeta Global upgraded to Outperform from Perform at Oppenheimer
02/07/22 Craig-Hallum
Craig-Hallum bullish on Zeta Global, initiates with a Buy
02/07/22 Craig-Hallum
Zeta Global initiated with a Buy at Craig-Hallum
11/16/21 Credit Suisse
Zeta Global initiated with a Neutral at Credit Suisse
AJRD Aerojet Rocketdyne
$41.75 /

+1.61 (+4.01%)

04/07/22 JPMorgan
Aerojet Rocketdyne upgraded to Overweight from Neutral at JPMorgan
02/24/22 Truist
Aerojet Rocketdyne price target lowered to $36 from $51 at Truist
02/08/22 Jefferies
Aerojet Rocketdyne upgraded to Buy at Jefferies on standalone fundamentals
02/08/22 Jefferies
Aerojet Rocketdyne upgraded to Buy from Hold at Jefferies
W Wayfair
$106.96 /

+0.02 (+0.02%)

04/07/22 Wells Fargo
Wayfair downgraded to Underweight from Equal Weight at Wells Fargo
04/01/22 Needham
Wayfair price target lowered to $150 from $180 at Needham
04/01/22 Barclays
Wayfair downgraded to sell on heightened risks at Barclays
04/01/22 Barclays
Wayfair downgraded to Underweight from Equal Weight at Barclays
F Ford
$15.00 /

-0.395 (-2.57%)

04/07/22 Barclays
Barclays downgrades Ford while cutting auto sector to Negative
04/07/22 Barclays
Ford downgraded to Equal Weight from Overweight at Barclays
03/28/22 Citi
Ford price target lowered to $18 from $23 at Citi
03/23/22 RBC Capital
RBC cut 2022, 2023 auto forecast on lingering supply chain issues
RAD Rite Aid
$6.69 /

-1.755 (-20.79%)

04/07/22 Deutsche Bank
Deutsche downgrades Rite Aid to Sell with $1 target into Q4 results
04/07/22 Deutsche Bank
Rite Aid downgraded to Sell from Hold at Deutsche Bank
10/20/21 Deutsche Bank
Rite Aid price target raised to $15 from $13 at Deutsche Bank
06/25/21
Fly Intel: Top five analyst downgrades
HLI Houlihan Lokey
$82.41 /

-1.82 (-2.16%)

04/07/22 Piper Sandler
Houlihan Lokey downgraded to Underweight from Neutral at Piper Sandler
04/07/22 Wolfe Research
PJT Partners upgraded to Outperform from Peer Perform at Wolfe Research
03/22/22 Piper Sandler
Houlihan Lokey price target lowered to $92 from $106 at Piper Sandler
03/09/22 Piper Sandler
Houlihan Lokey price target lowered to $106 from $122 at Piper Sandler
HIMX Himax
$9.71 /

-0.705 (-6.77%)

04/07/22 Nomura
Himax downgraded to Neutral from Buy at Nomura
09/17/21 Vertical Group
Himax downgraded to Sell from Neutral at Vertical Group
RBLX Roblox
$45.44 /

-0.41 (-0.89%)

04/07/22 Citi
Roblox initiated with a Buy at Citi
03/30/22 MKM Partners
Roblox initiated with a Neutral at MKM Partners
03/28/22 Daiwa
Roblox initiated with an Outperform at Daiwa
03/16/22 Stifel
Roblox price target lowered to $65 from $90 at Stifel
U Unity
$93.82 /

+ (+0.00%)

04/07/22 Citi
Unity Software initiated with a Buy at Citi
03/28/22 Daiwa
Unity Software initiated with an Outperform at Daiwa
03/21/22 Stifel
Unity Software price target lowered to $150 from $160 at Stifel
03/08/22 Jefferies
Unity Software initiated with a Hold at Jefferies
TDOC Teladoc
$67.96 /

+0.185 (+0.27%)

04/07/22 Guggenheim
Guggenheim starts Teladoc at Buy with $96 price target
04/06/22 Guggenheim
Teladoc initiated with a Buy at Guggenheim
03/31/22 Credit Suisse
Teladoc assumed with an Outperform at Credit Suisse
03/17/22 Citi
Teladoc price target lowered to $115 from $132 at Citi
SYNA Synaptics
$168.70 /

-1.35 (-0.79%)

04/07/22 Wells Fargo
Synaptics initiated with an Equal Weight at Wells Fargo
02/04/22 Needham
Synaptics price target raised to $340 from $320 at Needham
01/13/22 Mizuho
Synaptics price target raised to $275 from $250 at Mizuho
12/15/21 Needham
Synaptics price target raised to $320 from $300 at Needham
DOCS Doximity
$50.85 /

-0.64 (-1.24%)

04/07/22 Guggenheim
Guggenheim starts Doximity at Buy with $70 price target
04/06/22 Guggenheim
Doximity initiated with a Buy at Guggenheim
04/04/22 BofA
BofA starts Doximity at Neutral, sees shares priced for sustainable growth
04/04/22 BofA
Doximity initiated with a Neutral at BofA
GDRX GoodRx
$18.90 /

+0.18 (+0.96%)

04/07/22 Guggenheim
Guggenheim starts 'undervalued' GoodRx at Buy
04/06/22 Guggenheim
GoodRx initiated with a Buy at Guggenheim
04/05/22 Baird
GoodRx price target raised to $23 from $17 at Baird
03/31/22 Credit Suisse
GoodRx assumed with a Neutral at Credit Suisse
CNVY Convey Health
$6.61 /

+0.12 (+1.85%)

04/07/22 Guggenheim
Guggenheim starts Convey Health at Buy with $12 price target
04/06/22 Guggenheim
Convey Health initiated with a Buy at Guggenheim
03/24/22 Canaccord
Convey Health price target lowered to $14 from $18 at Canaccord
02/11/22 Goldman Sachs
Convey Health initiated with a Neutral at Goldman Sachs
HQY HealthEquity
$67.50 /

+ (+0.00%)

04/07/22 Guggenheim
Guggenheim starts HealthEquity at Buy with $89 price target
04/06/22 Guggenheim
HealthEquity initiated with a Buy at Guggenheim
03/30/22 BTIG
HealthEquity upgraded to Buy at BTIG on higher utilization of healthcare service
03/30/22 BTIG
HealthEquity upgraded to Buy from Neutral at BTIG
ACCD Accolade
$15.97 /

-0.7 (-4.20%)

04/07/22 Guggenheim
Guggenheim starts Accolade at Neutral, sees lack of profit to limit performance
04/06/22 Guggenheim
Accolade initiated with a Neutral at Guggenheim
03/31/22 Credit Suisse
Accolade assumed with an Outperform at Credit Suisse
03/03/22 Credit Suisse
Accolade price target lowered to $33 from $43 at Credit Suisse
ZETA Zeta Global
$12.50 /

+0.395 (+3.26%)

YETI Yeti
$56.09 /

+1.14 (+2.07%)

W Wayfair
$106.96 /

+0.02 (+0.02%)

U Unity
$93.82 /

+ (+0.00%)

TDOC Teladoc
$67.96 /

+0.185 (+0.27%)

SYNA Synaptics
$168.70 /

-1.35 (-0.79%)

RBLX Roblox
$45.44 /

-0.41 (-0.89%)

RAD Rite Aid
$6.69 /

-1.755 (-20.79%)

HQY HealthEquity
$67.50 /

+ (+0.00%)

HLI Houlihan Lokey
$82.41 /

-1.82 (-2.16%)

GDRX GoodRx
$18.90 /

+0.18 (+0.96%)

F Ford
$15.00 /

-0.395 (-2.57%)

DOCS Doximity
$50.85 /

-0.64 (-1.24%)

CNVY Convey Health
$6.61 /

+0.12 (+1.85%)

ARRY Array Technologies
$10.42 /

-0.585 (-5.32%)

AN AutoNation
$98.53 /

+0.74 (+0.76%)

AJRD Aerojet Rocketdyne
$41.75 /

+1.61 (+4.01%)

ACCD Accolade
$15.97 /

-0.7 (-4.20%)

  • 17
    Aug
  • 24
    Jun
  • 16
    Jun
  • 10
    Jun
TDOC Teladoc
$67.96 /

+0.185 (+0.27%)

SYNA Synaptics
$168.70 /

-1.35 (-0.79%)

RBLX Roblox
$45.44 /

-0.41 (-0.89%)

RAD Rite Aid
$6.69 /

-1.755 (-20.79%)

HLI Houlihan Lokey
$82.41 /

-1.82 (-2.16%)

F Ford
$15.00 /

-0.395 (-2.57%)

ARRY Array Technologies
$10.42 /

-0.585 (-5.32%)

AJRD Aerojet Rocketdyne
$41.75 /

+1.61 (+4.01%)

ZETA Zeta Global
$12.50 /

+0.395 (+3.26%)

YETI Yeti
$56.09 /

+1.14 (+2.07%)

W Wayfair
$106.96 /

+0.02 (+0.02%)

U Unity
$93.82 /

+ (+0.00%)

TDOC Teladoc
$67.96 /

+0.185 (+0.27%)

RBLX Roblox
$45.44 /

-0.41 (-0.89%)

RAD Rite Aid
$6.69 /

-1.755 (-20.79%)

HQY HealthEquity
$67.50 /

+ (+0.00%)

GDRX GoodRx
$18.90 /

+0.18 (+0.96%)

F Ford
$15.00 /

-0.395 (-2.57%)

DOCS Doximity
$50.85 /

-0.64 (-1.24%)

ARRY Array Technologies
$10.42 /

-0.585 (-5.32%)

AN AutoNation
$98.53 /

+0.74 (+0.76%)

AJRD Aerojet Rocketdyne
$41.75 /

+1.61 (+4.01%)

ACCD Accolade
$15.97 /

-0.7 (-4.20%)

ZETA Zeta Global
$12.50 /

+0.395 (+3.26%)

YETI Yeti
$56.09 /

+1.14 (+2.07%)

W Wayfair
$106.96 /

+0.02 (+0.02%)

U Unity
$93.82 /

+ (+0.00%)

TDOC Teladoc
$67.96 /

+0.185 (+0.27%)

SYNA Synaptics
$168.70 /

-1.35 (-0.79%)

RBLX Roblox
$45.44 /

-0.41 (-0.89%)

RAD Rite Aid
$6.69 /

-1.755 (-20.79%)

HQY HealthEquity
$67.50 /

+ (+0.00%)

HIMX Himax
$9.71 /

-0.705 (-6.77%)

F Ford
$15.00 /

-0.395 (-2.57%)

DOCS Doximity
$50.85 /

-0.64 (-1.24%)

ARRY Array Technologies
$10.42 /

-0.585 (-5.32%)

ACCD Accolade
$15.97 /

-0.7 (-4.20%)

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.